Clinical Trial: Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878924) titled 'Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation' on March 05.

Brief Summary: This study is designed to directly compare the safety and efficacy of PFA-based PVI+PWI vs PFA-based PVI+ VoM alcohol ablation in patients with Persistent AF.

Study Start Date: May, 2025

Study Type: OBSERVATIONAL

Condition: Atrial Fibrillation (AF)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Texas Cardiac Arrhythmia Research Foundation

Information provided by (R...